Taken together, our analysis reveals that SkM from middle-aged individuals with obesity exhibit increased CS markers which are associated with a dysmetabolic state, reduced expression of key metabolic gene GLUT4 and diminished levels of PAX7, which is crucial for the maintenance and development of SkM. The gene discussed is SLC2A4; the disease is obesity due to melanocortin 4 receptor deficiency.